Drug-eluting stents do not increase the risk of stent thrombosis, but longer stents may be associated with greater incidence of thrombosis: Commentary

Evidence-based Cardiovascular Medicine

Volumn 9, Issue 3, 2005, Pages 184-186

  Pandhi, P ^a   Shafiq, N ^a   Malhotra, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; METAL; PACLITAXEL; RAPAMYCIN;

AGING; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY STENT; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; EQUIPMENT DESIGN; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INCIDENCE; LONG TERM CARE; MEDICAL INSTRUMENTATION; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STENT HROMBOSIS; THROMBOSIS;

EID: 23844433326     PISSN: 13612611     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ebcm.2005.06.034     Document Type: Article

References (7)

1. Shafiq N, Malhotra S, Pandhi P, et al. A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease. Br J Clin Pharmacol 2005;59:94-101.
2. Katritsis DG, Karvouni E, Loannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol 2005;95:640-43.
3. Honda Y, Fitzgrald PJ. Stent thrombosis. An issue revisited in a changing world. Circulation 2003;109:2-5.
4. Schuhlen H, Kastrati A, Dirschinger J, et al. Intracoronary stenting and risk of major adverse cardiac events during the first month. Circulation 1998;98:104-11.
5. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-71.
6. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regiments after coronary-artery stenting. Stent Anti-coagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-71.
7. Kastrati A, Schulen H, Hausleiter J, et al. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: Six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation 1997;96:462-7.